- Mould Detection: Identifies harmful mould species present in your environment.
- Biotoxin Analysis: Tests for toxic substances produced by mould.
- Health Impact Assessment: Evaluates potential health risks related to mould exposure.
- Easy Sample Collection: Simple at-home or professional testing process.
- Fast Results & Recommendations: Quick results with tailored advice for remediation.
$585.00
This panel looks at how your body is responding to possible mould or biotoxins — more of an indirect measure.
If you are wanting to directly confirm mould exposure by detecting mycotoxins in your body, from your urine, we recommend the RN Labs Mycotox Profile.
C3a, C4a, VIP, and MSH are important biomarkers involved various physiological and pathological processes, contributing to immune responses, inflammation, and neuroendocrine regulation (1).
C3a and C4a are components of the complement system, playing crucial roles in immune responses.
Elevated levels of C3a and C4a may indicate excessive immune activation, as seen in chronic inflammation (1).
VIP (Vasoactive Intestinal Peptide) is a neuroregulatory hormone with anti-inflammatory properties. It regulates immune responses, gastrointestinal function, circadian rhythms, and inf lammatory responses, and is an important marker for those affected by mould exposure (1).
MSH (Melanocyte-Stimulating Hormone) is part of the melanocortin system and plays a role in regulating inflammation, appetite, and skin pigmentation. Dysregulation of MSH is linked to conditions like obesity, skin disorders, sleep disorders and chronic pain (1).
Test Method
EIA, RIA
Analytes
- 3402: C3a, C4a, MMP9, TGFB1, VEGF (Included in this test)
Common Conditions
- Chronic Inflammation
- Obesity
- Chronic pain
- CIRS
- Fatigue
- Fibromyalgia
- Insomnia and sleep disturbances
- Malaise
- Mould/ mold exposure
- Neurological disorders
- Poor immunity
- Gastrointestinal issues
- Mental health
- Skin disorders
Important Note:
Mould and mycotoxin testing can be a helpful screening tool to assess the level of mycotoxins being excreted at a particular point in time. However, results should always be interpreted with care, as the absence of elevated markers does not completely rule out mould exposure, mycotoxin burden, gastrointestinal colonisation, or mould-related illness.
Mycotoxin excretion can be influenced by many factors, including the length and intensity of exposure, liver and kidney function, gastrointestinal health, detoxification capacity, current symptoms, timing of sample collection, and individual biological variation. Long-term or high-level exposure may also place additional stress on elimination organs such as the liver and kidneys, which may affect the body’s ability to process and excrete mycotoxins.
It is also important to understand that different laboratories may produce different results due to variations in testing methods, equipment sensitivity, calibration, and reporting thresholds. We use Mosaic Diagnostics, a well-regarded laboratory that undergoes third-party auditing to support consistency, reproducibility, and accuracy. Their laboratory certifications and regulatory information can be viewed on their website.
While this testing can provide valuable insight, it may not always provide a definitive answer. Results are best interpreted alongside your symptoms, health history, environmental exposure, and clinical presentation. If you have ongoing symptoms or concerns about mould exposure, we recommend booking a consultation so your results can be reviewed in context.
